GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: GS-6615 | GS6615
Compound class:
Synthetic organic
Comment: Eleclazine is a sodium channel inhibitor, modulating cardiac late Na+ currents via the Nav1.5 (gene symbol SCN5A) channel. The compound is a dihydrobenzodiazepine type structure. Dihydrobenzodiazepine scaffolds are being developed as α-helix mimetics, with the potential to inhibit protein-protein interactions [1,3-5]. This chemical structure and its use is covered by patent US20150038489 [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9978 | eleclazine |
Synonyms ![]() |
| GS-6615 | GS6615 |
Database Links ![]() |
|
| CAS Registry No. | 1443211-72-0 |
| GtoPdb PubChem SID | 252166623 |
| PubChem CID | 71183216 |
| Search Google for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YNUAEEJQYHYLMS |
| Search PubMed clinical trials | eleclazine |
| Search PubMed titles | eleclazine |
| Search PubMed titles/abstracts | eleclazine |
| UniChem Compound Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |